ONEST in Breast Cancer and Its Limitations

Tumour-infiltrating lymphocytes (TILs) reflect the host's response against tumours. TILs have a strong prognostic effect in the so-called triple-negative (oestrogen receptor, progesterone receptor, and human epidermal growth factor receptor-2 negative) subset of breast cancers and predict a bet...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Cancers 2023-02, Vol.15 (4)
Hauptverfasser: Cserni, Bálint, Kilma, O’Loughlin, Mark, Andreu, Xavier, Bagó-Horváth, Zsuzsanna, Bianchi, Simonetta, Chmielik, Ewa, Figueiredo, Paulo, Floris, Giuseppe, Foschini, Maria Pia, Kovács, Anikó, Heikkilä, Päivi, Kulka, Janina, Laenkholm, Anne-Vibeke, Liepniece-Karele, Inta, Marchiò, Caterina, Provenzano, Elena, Regitnig, Peter, Reiner, Angelika, Ryška, Aleš, Sapino, Anna, Stovgaard, Elisabeth Specht, Quinn, Cecily, Zolota, Vasiliki, Webber, Mark, Glynn, Sharon A, Bori, Rita, Csörgő, Erika, Oláh-Németh, Orsolya, Pancsa, Tamás, Sejben, Anita, Sejben, István, Vörös, András, Zombori, Tamás, Nyári, Tibor, Callagy, Grace, Cserni, Gábor
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue 4
container_start_page
container_title Cancers
container_volume 15
creator Cserni, Bálint
Kilma
O’Loughlin, Mark
Andreu, Xavier
Bagó-Horváth, Zsuzsanna
Bianchi, Simonetta
Chmielik, Ewa
Figueiredo, Paulo
Floris, Giuseppe
Foschini, Maria Pia
Kovács, Anikó
Heikkilä, Päivi
Kulka, Janina
Laenkholm, Anne-Vibeke
Liepniece-Karele, Inta
Marchiò, Caterina
Provenzano, Elena
Regitnig, Peter
Reiner, Angelika
Ryška, Aleš
Sapino, Anna
Stovgaard, Elisabeth Specht
Quinn, Cecily
Zolota, Vasiliki
Webber, Mark
Glynn, Sharon A
Bori, Rita
Csörgő, Erika
Oláh-Németh, Orsolya
Pancsa, Tamás
Sejben, Anita
Sejben, István
Vörös, András
Zombori, Tamás
Nyári, Tibor
Callagy, Grace
Cserni, Gábor
description Tumour-infiltrating lymphocytes (TILs) reflect the host's response against tumours. TILs have a strong prognostic effect in the so-called triple-negative (oestrogen receptor, progesterone receptor, and human epidermal growth factor receptor-2 negative) subset of breast cancers and predict a better response when primary systemic (neoadjuvant) treatment is administered. Although they are easy to assess, their quantitative assessment is subject to some inter-observer variation. ONEST (Observers Needed to Evaluate Subjective Tests) is a new way of analysing inter-observer variability and helps in estimating the number of observers required for a more reliable estimation of this phenomenon. This aspect of reproducibility for TILs has not been explored previously. Our analysis suggests that between six and nine pathologists can give a good approximation of inter-observer agreement in TIL assessments. Tumour-infiltrating lymphocytes (TILs) reflect antitumour immunity. Their evaluation of histopathology specimens is influenced by several factors and is subject to issues of reproducibility. ONEST (Observers Needed to Evaluate Subjective Tests) helps in determining the number of observers that would be sufficient for the reliable estimation of inter-observer agreement of TIL categorisation. This has not been explored previously in relation to TILs. ONEST analyses, using an open-source software developed by the first author, were performed on TIL quantification in breast cancers taken from two previous studies. These were one reproducibility study involving 49 breast cancers, 23 in the first circulation and 14 pathologists in the second circulation, and one study involving 100 cases and 9 pathologists. In addition to the estimates of the number of observers required, other factors influencing the results of ONEST were examined. The analyses reveal that between six and nine observers (range 2-11) are most commonly needed to give a robust estimate of reproducibility. In addition, the number and experience of observers, the distribution of values around or away from the extremes, and outliers in the classification also influence the results. Due to the simplicity and the potentially relevant information it may give, we propose ONEST to be a part of new reproducibility analyses.
doi_str_mv 10.3390/cancers15041199
format Article
fullrecord <record><control><sourceid>gale</sourceid><recordid>TN_cdi_gale_infotracmisc_A743010315</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A743010315</galeid><sourcerecordid>A743010315</sourcerecordid><originalsourceid>FETCH-LOGICAL-g675-1f16aa1bb65c0839e8a6ef9930c478592b3ab2561b28041ab1169cefd05644fd3</originalsourceid><addsrcrecordid>eNptjr1rwzAQxUVpoCHN3FXQreBUZ31ZY2rSNGCaId7DSZaCSiyD5f-fmrZDht4N73G89-MIeQK24dywV4fJ-TGDZALAmDuyLJkuC6WMuL_xD2Sd8xebh3PQSi_Jy_Fzd2ppTPRt9JgnWv-QKKaOHqZMm9jHCac4pPxIFgGv2a__dEXa911bfxTNcX-ot01xUVoWEEAhgrVKOlZx4ytUPhjDmRO6kqa0HG0pFdiymp9FC6CM86FjUgkROr4iz7_YC179OaYwTCO6PmZ33mrBGTAOck5t_knN2_k-uiH5EOf7TeEbY3dSUw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>ONEST in Breast Cancer and Its Limitations</title><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central Open Access</source><source>MDPI - Multidisciplinary Digital Publishing Institute</source><source>PubMed Central</source><creator>Cserni, Bálint ; Kilma ; O’Loughlin, Mark ; Andreu, Xavier ; Bagó-Horváth, Zsuzsanna ; Bianchi, Simonetta ; Chmielik, Ewa ; Figueiredo, Paulo ; Floris, Giuseppe ; Foschini, Maria Pia ; Kovács, Anikó ; Heikkilä, Päivi ; Kulka, Janina ; Laenkholm, Anne-Vibeke ; Liepniece-Karele, Inta ; Marchiò, Caterina ; Provenzano, Elena ; Regitnig, Peter ; Reiner, Angelika ; Ryška, Aleš ; Sapino, Anna ; Stovgaard, Elisabeth Specht ; Quinn, Cecily ; Zolota, Vasiliki ; Webber, Mark ; Glynn, Sharon A ; Bori, Rita ; Csörgő, Erika ; Oláh-Németh, Orsolya ; Pancsa, Tamás ; Sejben, Anita ; Sejben, István ; Vörös, András ; Zombori, Tamás ; Nyári, Tibor ; Callagy, Grace ; Cserni, Gábor</creator><creatorcontrib>Cserni, Bálint ; Kilma ; O’Loughlin, Mark ; Andreu, Xavier ; Bagó-Horváth, Zsuzsanna ; Bianchi, Simonetta ; Chmielik, Ewa ; Figueiredo, Paulo ; Floris, Giuseppe ; Foschini, Maria Pia ; Kovács, Anikó ; Heikkilä, Päivi ; Kulka, Janina ; Laenkholm, Anne-Vibeke ; Liepniece-Karele, Inta ; Marchiò, Caterina ; Provenzano, Elena ; Regitnig, Peter ; Reiner, Angelika ; Ryška, Aleš ; Sapino, Anna ; Stovgaard, Elisabeth Specht ; Quinn, Cecily ; Zolota, Vasiliki ; Webber, Mark ; Glynn, Sharon A ; Bori, Rita ; Csörgő, Erika ; Oláh-Németh, Orsolya ; Pancsa, Tamás ; Sejben, Anita ; Sejben, István ; Vörös, András ; Zombori, Tamás ; Nyári, Tibor ; Callagy, Grace ; Cserni, Gábor</creatorcontrib><description>Tumour-infiltrating lymphocytes (TILs) reflect the host's response against tumours. TILs have a strong prognostic effect in the so-called triple-negative (oestrogen receptor, progesterone receptor, and human epidermal growth factor receptor-2 negative) subset of breast cancers and predict a better response when primary systemic (neoadjuvant) treatment is administered. Although they are easy to assess, their quantitative assessment is subject to some inter-observer variation. ONEST (Observers Needed to Evaluate Subjective Tests) is a new way of analysing inter-observer variability and helps in estimating the number of observers required for a more reliable estimation of this phenomenon. This aspect of reproducibility for TILs has not been explored previously. Our analysis suggests that between six and nine pathologists can give a good approximation of inter-observer agreement in TIL assessments. Tumour-infiltrating lymphocytes (TILs) reflect antitumour immunity. Their evaluation of histopathology specimens is influenced by several factors and is subject to issues of reproducibility. ONEST (Observers Needed to Evaluate Subjective Tests) helps in determining the number of observers that would be sufficient for the reliable estimation of inter-observer agreement of TIL categorisation. This has not been explored previously in relation to TILs. ONEST analyses, using an open-source software developed by the first author, were performed on TIL quantification in breast cancers taken from two previous studies. These were one reproducibility study involving 49 breast cancers, 23 in the first circulation and 14 pathologists in the second circulation, and one study involving 100 cases and 9 pathologists. In addition to the estimates of the number of observers required, other factors influencing the results of ONEST were examined. The analyses reveal that between six and nine observers (range 2-11) are most commonly needed to give a robust estimate of reproducibility. In addition, the number and experience of observers, the distribution of values around or away from the extremes, and outliers in the classification also influence the results. Due to the simplicity and the potentially relevant information it may give, we propose ONEST to be a part of new reproducibility analyses.</description><identifier>ISSN: 2072-6694</identifier><identifier>EISSN: 2072-6694</identifier><identifier>DOI: 10.3390/cancers15041199</identifier><language>eng</language><publisher>MDPI AG</publisher><subject>Health aspects ; Lymphocytes</subject><ispartof>Cancers, 2023-02, Vol.15 (4)</ispartof><rights>COPYRIGHT 2023 MDPI AG</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids></links><search><creatorcontrib>Cserni, Bálint</creatorcontrib><creatorcontrib>Kilma</creatorcontrib><creatorcontrib>O’Loughlin, Mark</creatorcontrib><creatorcontrib>Andreu, Xavier</creatorcontrib><creatorcontrib>Bagó-Horváth, Zsuzsanna</creatorcontrib><creatorcontrib>Bianchi, Simonetta</creatorcontrib><creatorcontrib>Chmielik, Ewa</creatorcontrib><creatorcontrib>Figueiredo, Paulo</creatorcontrib><creatorcontrib>Floris, Giuseppe</creatorcontrib><creatorcontrib>Foschini, Maria Pia</creatorcontrib><creatorcontrib>Kovács, Anikó</creatorcontrib><creatorcontrib>Heikkilä, Päivi</creatorcontrib><creatorcontrib>Kulka, Janina</creatorcontrib><creatorcontrib>Laenkholm, Anne-Vibeke</creatorcontrib><creatorcontrib>Liepniece-Karele, Inta</creatorcontrib><creatorcontrib>Marchiò, Caterina</creatorcontrib><creatorcontrib>Provenzano, Elena</creatorcontrib><creatorcontrib>Regitnig, Peter</creatorcontrib><creatorcontrib>Reiner, Angelika</creatorcontrib><creatorcontrib>Ryška, Aleš</creatorcontrib><creatorcontrib>Sapino, Anna</creatorcontrib><creatorcontrib>Stovgaard, Elisabeth Specht</creatorcontrib><creatorcontrib>Quinn, Cecily</creatorcontrib><creatorcontrib>Zolota, Vasiliki</creatorcontrib><creatorcontrib>Webber, Mark</creatorcontrib><creatorcontrib>Glynn, Sharon A</creatorcontrib><creatorcontrib>Bori, Rita</creatorcontrib><creatorcontrib>Csörgő, Erika</creatorcontrib><creatorcontrib>Oláh-Németh, Orsolya</creatorcontrib><creatorcontrib>Pancsa, Tamás</creatorcontrib><creatorcontrib>Sejben, Anita</creatorcontrib><creatorcontrib>Sejben, István</creatorcontrib><creatorcontrib>Vörös, András</creatorcontrib><creatorcontrib>Zombori, Tamás</creatorcontrib><creatorcontrib>Nyári, Tibor</creatorcontrib><creatorcontrib>Callagy, Grace</creatorcontrib><creatorcontrib>Cserni, Gábor</creatorcontrib><title>ONEST in Breast Cancer and Its Limitations</title><title>Cancers</title><description>Tumour-infiltrating lymphocytes (TILs) reflect the host's response against tumours. TILs have a strong prognostic effect in the so-called triple-negative (oestrogen receptor, progesterone receptor, and human epidermal growth factor receptor-2 negative) subset of breast cancers and predict a better response when primary systemic (neoadjuvant) treatment is administered. Although they are easy to assess, their quantitative assessment is subject to some inter-observer variation. ONEST (Observers Needed to Evaluate Subjective Tests) is a new way of analysing inter-observer variability and helps in estimating the number of observers required for a more reliable estimation of this phenomenon. This aspect of reproducibility for TILs has not been explored previously. Our analysis suggests that between six and nine pathologists can give a good approximation of inter-observer agreement in TIL assessments. Tumour-infiltrating lymphocytes (TILs) reflect antitumour immunity. Their evaluation of histopathology specimens is influenced by several factors and is subject to issues of reproducibility. ONEST (Observers Needed to Evaluate Subjective Tests) helps in determining the number of observers that would be sufficient for the reliable estimation of inter-observer agreement of TIL categorisation. This has not been explored previously in relation to TILs. ONEST analyses, using an open-source software developed by the first author, were performed on TIL quantification in breast cancers taken from two previous studies. These were one reproducibility study involving 49 breast cancers, 23 in the first circulation and 14 pathologists in the second circulation, and one study involving 100 cases and 9 pathologists. In addition to the estimates of the number of observers required, other factors influencing the results of ONEST were examined. The analyses reveal that between six and nine observers (range 2-11) are most commonly needed to give a robust estimate of reproducibility. In addition, the number and experience of observers, the distribution of values around or away from the extremes, and outliers in the classification also influence the results. Due to the simplicity and the potentially relevant information it may give, we propose ONEST to be a part of new reproducibility analyses.</description><subject>Health aspects</subject><subject>Lymphocytes</subject><issn>2072-6694</issn><issn>2072-6694</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid/><recordid>eNptjr1rwzAQxUVpoCHN3FXQreBUZ31ZY2rSNGCaId7DSZaCSiyD5f-fmrZDht4N73G89-MIeQK24dywV4fJ-TGDZALAmDuyLJkuC6WMuL_xD2Sd8xebh3PQSi_Jy_Fzd2ppTPRt9JgnWv-QKKaOHqZMm9jHCac4pPxIFgGv2a__dEXa911bfxTNcX-ot01xUVoWEEAhgrVKOlZx4ytUPhjDmRO6kqa0HG0pFdiymp9FC6CM86FjUgkROr4iz7_YC179OaYwTCO6PmZ33mrBGTAOck5t_knN2_k-uiH5EOf7TeEbY3dSUw</recordid><startdate>20230201</startdate><enddate>20230201</enddate><creator>Cserni, Bálint</creator><creator>Kilma</creator><creator>O’Loughlin, Mark</creator><creator>Andreu, Xavier</creator><creator>Bagó-Horváth, Zsuzsanna</creator><creator>Bianchi, Simonetta</creator><creator>Chmielik, Ewa</creator><creator>Figueiredo, Paulo</creator><creator>Floris, Giuseppe</creator><creator>Foschini, Maria Pia</creator><creator>Kovács, Anikó</creator><creator>Heikkilä, Päivi</creator><creator>Kulka, Janina</creator><creator>Laenkholm, Anne-Vibeke</creator><creator>Liepniece-Karele, Inta</creator><creator>Marchiò, Caterina</creator><creator>Provenzano, Elena</creator><creator>Regitnig, Peter</creator><creator>Reiner, Angelika</creator><creator>Ryška, Aleš</creator><creator>Sapino, Anna</creator><creator>Stovgaard, Elisabeth Specht</creator><creator>Quinn, Cecily</creator><creator>Zolota, Vasiliki</creator><creator>Webber, Mark</creator><creator>Glynn, Sharon A</creator><creator>Bori, Rita</creator><creator>Csörgő, Erika</creator><creator>Oláh-Németh, Orsolya</creator><creator>Pancsa, Tamás</creator><creator>Sejben, Anita</creator><creator>Sejben, István</creator><creator>Vörös, András</creator><creator>Zombori, Tamás</creator><creator>Nyári, Tibor</creator><creator>Callagy, Grace</creator><creator>Cserni, Gábor</creator><general>MDPI AG</general><scope/></search><sort><creationdate>20230201</creationdate><title>ONEST in Breast Cancer and Its Limitations</title><author>Cserni, Bálint ; Kilma ; O’Loughlin, Mark ; Andreu, Xavier ; Bagó-Horváth, Zsuzsanna ; Bianchi, Simonetta ; Chmielik, Ewa ; Figueiredo, Paulo ; Floris, Giuseppe ; Foschini, Maria Pia ; Kovács, Anikó ; Heikkilä, Päivi ; Kulka, Janina ; Laenkholm, Anne-Vibeke ; Liepniece-Karele, Inta ; Marchiò, Caterina ; Provenzano, Elena ; Regitnig, Peter ; Reiner, Angelika ; Ryška, Aleš ; Sapino, Anna ; Stovgaard, Elisabeth Specht ; Quinn, Cecily ; Zolota, Vasiliki ; Webber, Mark ; Glynn, Sharon A ; Bori, Rita ; Csörgő, Erika ; Oláh-Németh, Orsolya ; Pancsa, Tamás ; Sejben, Anita ; Sejben, István ; Vörös, András ; Zombori, Tamás ; Nyári, Tibor ; Callagy, Grace ; Cserni, Gábor</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-g675-1f16aa1bb65c0839e8a6ef9930c478592b3ab2561b28041ab1169cefd05644fd3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Health aspects</topic><topic>Lymphocytes</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Cserni, Bálint</creatorcontrib><creatorcontrib>Kilma</creatorcontrib><creatorcontrib>O’Loughlin, Mark</creatorcontrib><creatorcontrib>Andreu, Xavier</creatorcontrib><creatorcontrib>Bagó-Horváth, Zsuzsanna</creatorcontrib><creatorcontrib>Bianchi, Simonetta</creatorcontrib><creatorcontrib>Chmielik, Ewa</creatorcontrib><creatorcontrib>Figueiredo, Paulo</creatorcontrib><creatorcontrib>Floris, Giuseppe</creatorcontrib><creatorcontrib>Foschini, Maria Pia</creatorcontrib><creatorcontrib>Kovács, Anikó</creatorcontrib><creatorcontrib>Heikkilä, Päivi</creatorcontrib><creatorcontrib>Kulka, Janina</creatorcontrib><creatorcontrib>Laenkholm, Anne-Vibeke</creatorcontrib><creatorcontrib>Liepniece-Karele, Inta</creatorcontrib><creatorcontrib>Marchiò, Caterina</creatorcontrib><creatorcontrib>Provenzano, Elena</creatorcontrib><creatorcontrib>Regitnig, Peter</creatorcontrib><creatorcontrib>Reiner, Angelika</creatorcontrib><creatorcontrib>Ryška, Aleš</creatorcontrib><creatorcontrib>Sapino, Anna</creatorcontrib><creatorcontrib>Stovgaard, Elisabeth Specht</creatorcontrib><creatorcontrib>Quinn, Cecily</creatorcontrib><creatorcontrib>Zolota, Vasiliki</creatorcontrib><creatorcontrib>Webber, Mark</creatorcontrib><creatorcontrib>Glynn, Sharon A</creatorcontrib><creatorcontrib>Bori, Rita</creatorcontrib><creatorcontrib>Csörgő, Erika</creatorcontrib><creatorcontrib>Oláh-Németh, Orsolya</creatorcontrib><creatorcontrib>Pancsa, Tamás</creatorcontrib><creatorcontrib>Sejben, Anita</creatorcontrib><creatorcontrib>Sejben, István</creatorcontrib><creatorcontrib>Vörös, András</creatorcontrib><creatorcontrib>Zombori, Tamás</creatorcontrib><creatorcontrib>Nyári, Tibor</creatorcontrib><creatorcontrib>Callagy, Grace</creatorcontrib><creatorcontrib>Cserni, Gábor</creatorcontrib><jtitle>Cancers</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Cserni, Bálint</au><au>Kilma</au><au>O’Loughlin, Mark</au><au>Andreu, Xavier</au><au>Bagó-Horváth, Zsuzsanna</au><au>Bianchi, Simonetta</au><au>Chmielik, Ewa</au><au>Figueiredo, Paulo</au><au>Floris, Giuseppe</au><au>Foschini, Maria Pia</au><au>Kovács, Anikó</au><au>Heikkilä, Päivi</au><au>Kulka, Janina</au><au>Laenkholm, Anne-Vibeke</au><au>Liepniece-Karele, Inta</au><au>Marchiò, Caterina</au><au>Provenzano, Elena</au><au>Regitnig, Peter</au><au>Reiner, Angelika</au><au>Ryška, Aleš</au><au>Sapino, Anna</au><au>Stovgaard, Elisabeth Specht</au><au>Quinn, Cecily</au><au>Zolota, Vasiliki</au><au>Webber, Mark</au><au>Glynn, Sharon A</au><au>Bori, Rita</au><au>Csörgő, Erika</au><au>Oláh-Németh, Orsolya</au><au>Pancsa, Tamás</au><au>Sejben, Anita</au><au>Sejben, István</au><au>Vörös, András</au><au>Zombori, Tamás</au><au>Nyári, Tibor</au><au>Callagy, Grace</au><au>Cserni, Gábor</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>ONEST in Breast Cancer and Its Limitations</atitle><jtitle>Cancers</jtitle><date>2023-02-01</date><risdate>2023</risdate><volume>15</volume><issue>4</issue><issn>2072-6694</issn><eissn>2072-6694</eissn><abstract>Tumour-infiltrating lymphocytes (TILs) reflect the host's response against tumours. TILs have a strong prognostic effect in the so-called triple-negative (oestrogen receptor, progesterone receptor, and human epidermal growth factor receptor-2 negative) subset of breast cancers and predict a better response when primary systemic (neoadjuvant) treatment is administered. Although they are easy to assess, their quantitative assessment is subject to some inter-observer variation. ONEST (Observers Needed to Evaluate Subjective Tests) is a new way of analysing inter-observer variability and helps in estimating the number of observers required for a more reliable estimation of this phenomenon. This aspect of reproducibility for TILs has not been explored previously. Our analysis suggests that between six and nine pathologists can give a good approximation of inter-observer agreement in TIL assessments. Tumour-infiltrating lymphocytes (TILs) reflect antitumour immunity. Their evaluation of histopathology specimens is influenced by several factors and is subject to issues of reproducibility. ONEST (Observers Needed to Evaluate Subjective Tests) helps in determining the number of observers that would be sufficient for the reliable estimation of inter-observer agreement of TIL categorisation. This has not been explored previously in relation to TILs. ONEST analyses, using an open-source software developed by the first author, were performed on TIL quantification in breast cancers taken from two previous studies. These were one reproducibility study involving 49 breast cancers, 23 in the first circulation and 14 pathologists in the second circulation, and one study involving 100 cases and 9 pathologists. In addition to the estimates of the number of observers required, other factors influencing the results of ONEST were examined. The analyses reveal that between six and nine observers (range 2-11) are most commonly needed to give a robust estimate of reproducibility. In addition, the number and experience of observers, the distribution of values around or away from the extremes, and outliers in the classification also influence the results. Due to the simplicity and the potentially relevant information it may give, we propose ONEST to be a part of new reproducibility analyses.</abstract><pub>MDPI AG</pub><doi>10.3390/cancers15041199</doi></addata></record>
fulltext fulltext
identifier ISSN: 2072-6694
ispartof Cancers, 2023-02, Vol.15 (4)
issn 2072-6694
2072-6694
language eng
recordid cdi_gale_infotracmisc_A743010315
source Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central Open Access; MDPI - Multidisciplinary Digital Publishing Institute; PubMed Central
subjects Health aspects
Lymphocytes
title ONEST in Breast Cancer and Its Limitations
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T03%3A32%3A47IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=ONEST%20in%20Breast%20Cancer%20and%20Its%20Limitations&rft.jtitle=Cancers&rft.au=Cserni,%20B%C3%A1lint&rft.date=2023-02-01&rft.volume=15&rft.issue=4&rft.issn=2072-6694&rft.eissn=2072-6694&rft_id=info:doi/10.3390/cancers15041199&rft_dat=%3Cgale%3EA743010315%3C/gale%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rft_galeid=A743010315&rfr_iscdi=true